Loading...
XSHG
600085
Market cap6.48bUSD
Dec 05, Last price  
33.42CNY
1D
0.51%
1Q
-4.76%
Jan 2017
6.60%
Name

Beijing Tongrentang Co Ltd

Chart & Performance

D1W1MN
XSHG:600085 chart
P/E
30.03
P/S
2.46
EPS
1.11
Div Yield, %
2.99%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
6.97%
Revenues
18.60b
+4.12%
2,605,732,4362,396,505,1762,702,850,9392,939,049,5113,250,219,8843,824,446,1416,108,383,7117,504,031,9778,714,647,4019,685,867,52210,808,761,22912,090,740,12213,375,966,34414,208,636,44613,277,123,19912,825,879,05014,603,100,73915,372,423,36317,860,891,45618,597,281,604
Net income
1.53b
-8.54%
301,231,159156,021,181232,891,142258,946,471285,610,659343,233,607438,066,654570,056,218656,013,728763,669,171875,179,501933,165,3911,017,381,5491,134,283,8471,561,601,3281,616,363,3051,890,760,4592,199,390,8111,668,834,5091,526,274,925
CFO
761m
-59.29%
191,538,984384,559,921121,020,805422,789,931627,689,915492,043,803544,905,320873,968,414676,398,667696,013,987832,472,8451,045,766,4821,448,915,1621,928,378,9942,273,710,5392,174,631,6633,426,414,5633,094,296,2841,869,491,851760,985,272
Dividend
Oct 10, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Hemiplegia recovery pills, etc. The company is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.
URL
https://gf.tongrentang.com/
IPO date
Jun 25, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT